Page 110 - JCTR-11-5

Journal of Clinical and
Translational Research Uric acid, CTGF genotype, and prostate cancer

doi: 10.5173/ceju.2018.1619 21. Nomura A, Stemmermann GN, Rhoads GG, Glober GA.
The Japan-Hawaii cancer study: A progress report. Hawaii
10. Singh S, Jaiswal S, Faujdar G, Priyadarshi S. Comparison
of serum uric acid levels between localized prostate cancer Med J. 1975;34:309-316.
patients and a control group. Urologia. 2024;91:320-325. 22. Heilbrun LK, Kagan A, Nomura A, Wasnich RD. The
doi: 10.1177/03915603241228892 origins of epidemiologic studies of heart disease, cancer
and osteoporosis among Hawaii Japanese. Hawaii Med J.
11. Yan Y, Lin H, He Z, Wang L. Serum uric acid and prostate 1985;44:294-296.
cancer: Findings from the NHANES (2007-2020). Front
Oncol. 2024;14:1354235. 23. Kagan A, editor. The Honolulu Heart Program: An
Epidemiological Study of Coronary Heart Disease and Stroke.
doi: 10.3389/fonc.2024.1354235 Amsterdam: Harwood Academic Publishers; 1996.
12. Jiang M, Ren L, Chen S, Li G. Serum uric acid levels and risk 24. Kolonel LN, Yoshizawa C, Nomura AM, Stemmermann GN.
of eight site-specific cancers: A Mendelian randomization Relationship of serum uric acid to cancer occurrence in a
study. Front Genet. 2021;12:608311. prospective male cohort. Cancer Epidemiol Biomarkers Prev.
doi: 10.3389/fgene.2021.608311 1994;3:225-228.
13. Wang A, Barber JR, Tin A, et al. Serum urate, genetic 25. Abbott RD, Rodriguez BL, Burchfiel CM, Curb JD. Physical
variation, and prostate cancer risk: Atherosclerosis risk in activity in older middle-aged men and reduced risk of stroke:
communities (ARIC) study. Cancer Epidemiol Biomarkers The honolulu heart program. Am J Epidemiol. 1994;139:
Prev. 2019;28:1259-1261. 881-893.
doi: 10.1158/1055-9965.EPI-19-0161 doi: 10.1093/oxfordjournals.aje.a117094
14. Kühn T, Sookthai D, Graf ME, et al. Albumin, bilirubin, uric 26. McGee DL, Reed DM, Yano K, Kagan A, Tillotson J. Ten-year
acid and cancer risk: Results from a prospective population- incidence of coronary heart disease in the honolulu heart
based study. Br J Cancer. 2017;117:1572-1579. program. Relationship to nutrient intake. Am J Epidemiol.
1984;119:667-676.
doi: 10.1038/bjc.2017.313
doi: 10.1093/oxfordjournals.aje.a113788
15. Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer
incidence in humans. Cancer Res. 1988;48:2916-2918. 27. Donlon TA, Morris BJ, He Q, et al. Association of
polymorphisms in connective tissue growth factor and
16. Li S, Shao R, Li S, et al. A monoallelic variant in CCN2 epidermal growth factor receptor genes with human
causes an autosomal dominant spondyloepimetaphyseal longevity. J Gerontol A Biol Sci Med Sci. 2017;72:1038-1045.
dysplasia with low bone mass. Bone Res. 2024;12:60.
doi: 10.1093/gerona/glw116
doi: 10.1038/s41413-024-00364-2
28. Ottman R. An epidemiologic approach to gene-environment
17. Shree B, Das K, Sharma V. Emerging role of transforming interaction. Genet Epidemiol. 1990;7:177-185.
growth factor-β-regulated long non-coding RNAs in prostate
cancer pathogenesis. Cancer Pathog Ther. 2022;1:195-204. doi: 10.1002/gepi.1370110108
doi: 10.1016/j.cpt.2022.12.003 29. Braga TT, Forni MF, Correa-Costa M, et al. Soluble uric acid
activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884.
18. Wikström P, Damber J, Bergh A. Role of transforming
growth factor-beta1 in prostate cancer. Microsc Res Tech. doi: 10.1038/srep39884
2001;52:411-419. 30. Strand DW, Liang YY, Yang F, et al. TGF-β induction of
doi: 10.1002/1097-0029(20010215)52:4<411:AID- FGF-2 expression in stromal cells requires integrated
JEMT1026>3.0.CO;2-8 smad3 and MAPK pathways. Am J Clin Exp Urol. 2014;2(3):
239-248.
19. Yang F, Tuxhorn JA, Ressler SJ, et al. Stromal expression of
connective tissue growth factor promotes angiogenesis and 31. Hanna A, Humeres C, Frangogiannis NG. The role of
prostate cancer tumorigenesis. Cancer Res. 2005;65:8887- smad signaling cascades in cardiac fibrosis. Cell Signal.
8895. 2021;77:109826.
doi: 10.1158/0008-5472.CAN-05-1702 doi: 10.1016/j.cellsig.2020.109826
20. Klück V, Cabău G, Mies L, et al. TGF-β is elevated in 32. Hall-Glenn F, De Young RA, Huang BL, et al. CCN2/
hyperuricemic individuals and mediates urate-induced connective tissue growth factor is essential for pericyte
hyperinflammatory phenotype in human mononuclear adhesion and endothelial basement membrane formation
cells. Arthritis Res Ther. 2023;25:30. during angiogenesis. PLoS One. 2012;7(2):e30562.
doi: 10.1186/s13075-023-03001-1 doi: 10.1371/journal.pone.0030562

Volume 11 Issue 5 (2025) 104 doi: 10.36922/JCTR025260029